Kenya may give the world the first vaccine to protect against gonorrhoea, which causes about 87 million infections annually. Once started, participants in the study – ‘Gonococcal Vaccine Study in Key Populations in Kenya,’ registration number NCT04297436, will get two doses of a meningitis vaccine, two months apart. The meningitis vaccine called Bexsero and licensed in about 35 countries, but not yet in Kenya, has been found to protect against gonorrhoea. The search for a gonorrhoea vaccine is informed by a stiff increase of infections across the world due to drug-resistant gonorrhoea strains. To increase the number of possible gonorrhoea vaccine targets the meeting suggested widening the net to capture adolescents aged 9-10.

Source: Standard Digital November 02, 2020 04:52 UTC